Treatment of Actinic Keratosis

Initial Assessment and Treatment Selection

For patients with actinic keratosis, the American Academy of Dermatology recommends using 5-fluorouracil (5-FU) as first-line field treatment for multiple lesions and cryosurgery for isolated individual lesions 1, 2
The choice between lesion-directed versus field-directed therapy depends on the number and distribution of lesions, with cryosurgery recommended for isolated or few lesions and topical 5-fluorouracil for multiple lesions or field cancerization 1
For thicker or hyperkeratotic lesions, consider curettage with histological examination, especially when suspecting early squamous cell carcinoma 3, 4

The American Academy of Dermatology strongly recommends 5% 5-FU cream as a first-line treatment, applied twice daily for 3-4 weeks, reducing approximately 70% of lesions for up to 12 months 1, 3
Imiquimod 5% cream is recommended as a second-line treatment, applied three times weekly for 16 weeks, achieving a 47% complete response rate 1, 2, 3
Diclofenac 3% gel is conditionally recommended as a third-line treatment due to moderate efficacy with low morbidity for mild actinic keratoses 2, 3

Cryosurgery is strongly recommended for isolated lesions, achieving a 75% complete response rate, with a double freeze-thaw cycle more effective than a single cycle 1, 2, 4
Photodynamic therapy (PDT) is conditionally recommended, particularly effective for confluent lesions on the scalp and difficult-to-treat areas, with lower risk of unfavorable scarring on legs compared to other physical therapies 1, 3

The American Academy of Dermatology recommends special attention to high-risk sites such as ears, periorbital area, legs, backs of hands, and scalp, with considerations for treatment modalities and potential complications 1, 2, 3, 4

Combination treatments such as diclofenac 3% followed by 5-FU 0.5% in 10% salicylic acid, or 5-FU 5% for 5-7 days as pretreatment, can enhance efficacy when combined with cryotherapy or PDT 3

The risk of progression to squamous cell carcinoma varies from less than 0.1% to 20% for individual lesions, with a cumulative risk of approximately 10% over 10 years for a patient with an average of 7.7 lesions 1, 2, 4
Higher risk is associated with immunosuppressed patients, advanced age, or previous skin cancer history 1

The American Academy of Dermatology strongly recommends UV protection in all patients with actinic keratosis, with regular use of high-index sunscreen reducing the appearance of new lesions 1, 2, 3, 4